Search research articles
Contact Us
Filters
Showing results (51-60 of 79) with videos related to
Page
of 8
Sort By:
La Radiologia Medica
|
November 3, 2025
Navigating discordant findings in multimodality imaging of prostate cancer in the MRI and PSMA-PET era
Sungmin Woo, Benedetta Masci, Anton S Becker, et al.
Journal of Magnetic Resonance Imaging : JMRI
|
April 22, 2025
Prostate Cancer Risk Stratification and Scan Tailoring Using Deep Learning on Abbreviated Prostate MRI
Patricia M Johnson, Tarun Dutt, Luke A Ginocchio, et al.
Frontiers in Oncology
|
March 18, 2025
Low incidence of significant hydrogel spacer rectal wall infiltration: results from an experienced high-volume center
Sungmin Woo, Anton S Becker, Aaron E Katz, et al.
World Journal of Urology
|
February 22, 2021
MRI predicts prostatic urethral involvement in men undergoing radical prostatectomy: implications for cryo-ablation of localized prostate cancer
Ezequiel Becher, Akash Sali, Andre Abreu, et al.
Abdominal Radiology (New York)
|
June 20, 2025
Head to toe: expand your diagnosis on routine imaging to include endometriosis
Anuradha S Shenoy-Bhangle, Carlos Carnelli, Angela Tong, et al.
Journal of Magnetic Resonance Imaging : JMRI
|
January 18, 2023
Comparison of a Deep Learning-Accelerated vs. Conventional T2-Weighted Sequence in Biparametric MRI of the Prostate
Angela Tong, Barun Bagga, Robert Petrocelli, et al.
European Radiology
|
January 24, 2025
Discordance between prostate MRI and PSMA-PET/CT: the next big challenge for primary prostate tumor assessment?
Sungmin Woo, Anton S Becker, Doris Leithner, et al.
Arxiv
|
May 3, 2023
FastMRI Prostate: A Publicly Available, Biparametric MRI Dataset to Advance Machine Learning for Prostate Cancer Imaging
Radhika Tibrewala, Tarun Dutt, Angela Tong, et al.
Journal of Managed Care & Specialty Pharmacy
|
December 28, 2018
Utilization Patterns of Oral Disease-Modifying Drugs in Commercially Insured Patients with Multiple Sclerosis
Rishi J Desai, Mufaddal Mahesri, Joshua J Gagne, et al.
Medical Care
|
May 15, 2012
Warnings without guidance: patient responses to an FDA warning about ezetimibe
William H Shrank, Niteesh K Choudhry, Angela Tong, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 79) with videos related to
Sort By:
Page
of 8
La Radiologia Medica
|
November 3, 2025
Navigating discordant findings in multimodality imaging of prostate cancer in the MRI and PSMA-PET era
Sungmin Woo, Benedetta Masci, Anton S Becker, et al.
Journal of Magnetic Resonance Imaging : JMRI
|
April 22, 2025
Prostate Cancer Risk Stratification and Scan Tailoring Using Deep Learning on Abbreviated Prostate MRI
Patricia M Johnson, Tarun Dutt, Luke A Ginocchio, et al.
Frontiers in Oncology
|
March 18, 2025
Low incidence of significant hydrogel spacer rectal wall infiltration: results from an experienced high-volume center
Sungmin Woo, Anton S Becker, Aaron E Katz, et al.
World Journal of Urology
|
February 22, 2021
MRI predicts prostatic urethral involvement in men undergoing radical prostatectomy: implications for cryo-ablation of localized prostate cancer
Ezequiel Becher, Akash Sali, Andre Abreu, et al.
Abdominal Radiology (New York)
|
June 20, 2025
Head to toe: expand your diagnosis on routine imaging to include endometriosis
Anuradha S Shenoy-Bhangle, Carlos Carnelli, Angela Tong, et al.
Journal of Magnetic Resonance Imaging : JMRI
|
January 18, 2023
Comparison of a Deep Learning-Accelerated vs. Conventional T2-Weighted Sequence in Biparametric MRI of the Prostate
Angela Tong, Barun Bagga, Robert Petrocelli, et al.
European Radiology
|
January 24, 2025
Discordance between prostate MRI and PSMA-PET/CT: the next big challenge for primary prostate tumor assessment?
Sungmin Woo, Anton S Becker, Doris Leithner, et al.
Arxiv
|
May 3, 2023
FastMRI Prostate: A Publicly Available, Biparametric MRI Dataset to Advance Machine Learning for Prostate Cancer Imaging
Radhika Tibrewala, Tarun Dutt, Angela Tong, et al.
Journal of Managed Care & Specialty Pharmacy
|
December 28, 2018
Utilization Patterns of Oral Disease-Modifying Drugs in Commercially Insured Patients with Multiple Sclerosis
Rishi J Desai, Mufaddal Mahesri, Joshua J Gagne, et al.
Medical Care
|
May 15, 2012
Warnings without guidance: patient responses to an FDA warning about ezetimibe
William H Shrank, Niteesh K Choudhry, Angela Tong, et al.
Page
of 8